Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021

MMWR Morbidity and Mortality Weekly Report(2021)10.15585/mmwr.mm7038e1Source: DataRank Database

Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021 is a research paper published in MMWR Morbidity and Mortality Weekly Report (2021). On theSindex it has a DataRank of 0. It has been cited 455 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access455 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: goldTopics (15)IDs (PubMed, PMC)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (99)

Mark W. Tenforde ORCID,Jillian P. Rhoads,Manjusha Gaglani ORCID,Adit A. Ginde ORCID,David J. Douin ORCID

Live enrichment

PubMed:34555004 PMC:PMC8459899

NHLBI NIH HHS

Grant: T32 HL087738

NIGMS NIH HHS

Grant: T32 GM135169

NIGMS NIH HHS

Grant: K23 GM129661

goldLicense: public-domain

publisherhttps://www.cdc.gov/mmwr/volumes/70/wr/pdfs/mm7038e1-H.pdf

repositoryhttp://europepmc.org/pmc/articles/PMC8459899

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8459899

Europe_PMChttps://europepmc.org/articles/PMC8459899

Europe_PMChttps://europepmc.org/articles/PMC8459899?pdf=render

MeSH Terms

HumansVaccines, SyntheticHospitalizationImmunocompromised HostAdolescentAdultAgedMiddle AgedUnited StatesFemaleMaleYoung AdultCOVID-19COVID-19 VaccinesmRNA Vaccines